Thermo Fisher Officer Files Intent to Sell $5.8M in Stock
THERMO FISHER SCIENTIFIC INC.
Subscribe to track TMO
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Thermo Fisher Officer Files Intent to Sell $5.8M in Stock
Company: THERMO FISHER SCIENTIFIC INC. (TMO) Form: 144 | Filed: 2025-11-07 Significance: Low
Insider: Britt Lisa P. Title: Officer
Transaction: • Type: Proposed Sale • Shares: 10,225 • Value: ~$5,844,850 • Price: ~$571.62/share
Key Insight: An officer has filed a notice of intent to sell shares valued at approximately $5.84 million. The shares originate from exercised options and vested restricted stock, common forms of executive compensation.
Market Context: This proposed sale represents a negligible percentage of both the company's market capitalization (0.0027%) and shares outstanding (0.0027%), suggesting it is likely a personal financial management transaction rather than a change in outlook on the company.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: THERMO FISHER SCIENTIFIC INC. (TMO)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An officer at Thermo Fisher has filed a notice of intent to sell 10,225 shares valued at approximately $5.84 million.
- Market Impact: The transaction is immaterial relative to the company's $213.27 billion market capitalization and is unlikely to influence the stock price.
Company Information
| Field | Value |
|---|---|
| Company | THERMO FISHER SCIENTIFIC INC. |
| Ticker Symbol | TMO |
| CIK | 0000097745 |
| Industry | Measuring & Controlling Devices, NEC |
Insider Information
| Field | Value |
|---|---|
| Name | Britt Lisa P. |
| CIK | 0001676320 |
| Title/Position | Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Transaction Date | 2025-11-07 (Approximate Sale Date) |
| Transaction Code | S (Proposed Sale) |
| Security Type | Common Stock |
| Shares Involved | 10,225 |
| Price Per Share | ~$571.62 |
| Total Value | $5,844,850.08 |
| Shares Owned After | Not Available |
| Ownership Type | Not Available |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $5,844,850.08 |
| % of Market Cap | 0.0027% |
| Shares Transacted | 10,225 |
| % of Shares Outstanding | 0.0027% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a mega-cap company like Thermo Fisher with a market capitalization of over $213 billion, a $5.84 million sale is a routine event and financially insignificant to the company's overall valuation.
- Transaction Significance: The sale represents a minuscule fraction of both market cap and shares outstanding, falling far below the thresholds for moderate or high significance. It is highly probable this is a pre-planned sale for personal liquidity or diversification purposes, common for executives receiving equity compensation.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction size is too small to have any material impact on a stock with a daily trading volume often in the hundreds of millions of dollars. It does not signal any meaningful change in the insider's perspective.
Volume & Sentiment
- Expected Volume Impact: Negligible. The sale will be easily absorbed by the market without any noticeable effect on trading volume.
- Sentiment Indicator: Neutral. This type of filing is standard for executives managing their compensation and does not typically influence market sentiment.
Additional Context
Transaction Notes
- Filing Type: This is a Form 144, which is a notice of proposed sale, not a completed transaction. The sale is expected to occur on or around November 7, 2025.
- Source of Shares: The filing indicates the shares to be sold were acquired through option exercises and the vesting of restricted stock units, which are standard components of executive compensation packages.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
